Biogen SG&A decreased by 11.0% to $607.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.1%, from $572.50M to $607.30M. Over 4 years (FY 2021 to FY 2025), SG&A shows relatively stable performance with a -2.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
A rising ratio of SG&A to revenue may indicate inefficiency or aggressive expansion, while a falling ratio suggests improved operating leverage.
Detailed definition
Selling, general, and administrative expenses encompass the costs associated with the day-to-day operation of the busine...
Peer comparison
Standard operating expense category; peers with larger global sales forces typically show higher absolute SG&A levels.
selling_general_and_administrativeHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $637.30M | $654.10M | $787.90M | $634.90M | $572.60M | $563.30M | $632.80M | $605.00M | $548.00M | $788.20M | $608.50M | $581.50M | $553.80M | $588.40M | $680.00M | $572.50M | $583.80M | $594.80M | $682.50M | $607.30M |
| QoQ Change | — | +2.6% | +20.5% | -19.4% | -9.8% | -1.6% | +12.3% | -4.4% | -9.4% | +43.8% | -22.8% | -4.4% | -4.8% | +6.2% | +15.6% | -15.8% | +2.0% | +1.9% | +14.7% | -11.0% |
| YoY Change | — | — | — | — | -10.2% | -13.9% | -19.7% | -4.7% | -4.3% | +39.9% | -3.8% | -3.9% | +1.1% | -25.3% | +11.8% | -1.5% | +5.4% | +1.1% | +0.4% | +6.1% |
Business Segments
| Segment | FY'22 | FY'23 | FY'24 | FY'25 |
|---|---|---|---|---|
| Reportable Segment | $2.40B | $2.55B | $2.40B | $2.43B |
| Total | $2.40B | $2.55B | $2.40B | $2.43B |
All segment values are derived from annual filings.
SG&A at Other Companies
Frequently Asked Questions
- What is Biogen's sg&a?
- Biogen (BIIB) reported sg&a of $607.30M in Q1 2026.
- How has Biogen's sg&a changed year-over-year?
- Biogen's sg&a increased by 6.1% year-over-year, from $572.50M to $607.30M.
- What is the long-term trend for Biogen's sg&a?
- Over 4 years (2021 to 2025), Biogen's sg&a has grown at a -2.3% compound annual growth rate (CAGR), from $2.67B to $2.43B.
- What does sg&a mean?
- The overhead costs of running the business, including sales, marketing, and general corporate expenses.